3,308 results match your criteria: "Hemangioblastoma"

Von Hippel-Lindau (vHL) is a hereditary disease characterized by the development of benign and malignant tumors across multiple organ systems. It is seen in approximately 1 in 36,000 live births. Given that vHL is a rare disease, studies that seek to characterize vHL are often hampered by small sample sizes.

View Article and Find Full Text PDF

Hemangioblastoma (HAB) is a benign, richly vascularized tumor that accounts for 2-6% of all spinal cord neoplasms and ranks third in the structure of intramedullary space-occupying lesions of the spinal cord. Hemangioblastoma may occur sporadically or, in approximately 30% of cases, as part of the clinical picture of a hereditary disease, von Hippel-Lindau disease. The aim of this study was to evaluate the efficacy and safety of stereotactic irradiation of hemangioblastomas of the spinal localization in patients with sporadic and von Hippel-Lindau-associated hemangioblastomas The results of stereotactic radiotherapy were evaluation of 210 spinal hemangioblastomas in 74 patients.

View Article and Find Full Text PDF

Glioma located on the right cerebellar hemisphere misdiagnosed as hemangioblastoma: A case report.

Asian J Surg

November 2024

Department of Neurosurgery, The Affiliated Huaian NO.1 People's Hospital of Nanjing Medical University, Nanjing Medical University, 1 West Huanghe Avenue, Huai'an, 223000, Jiangsu, China. Electronic address:

View Article and Find Full Text PDF

Background: Hemangioblastomas are highly vascularized tumors that may be associated with extensive architecture of the surrounding pathological vessels. The distinction between feeding arteries and draining veins is usually not obvious during microsurgical en-bloc tumor resection. The aim of this investigation is to provide recommendations in which hemangioblastomas intraoperative indocyanine green (ICG) videoangiography might be beneficial for safe en-bloc tumor resection.

View Article and Find Full Text PDF
Article Synopsis
  • Hemangioblastoma is a rare type of spinal cord tumor, making up only 1-5% of such cases, particularly notable in this report is the cervical intradural extramedullary hemangioblastoma without Von Hippel-Lindau syndrome, which has never been documented in China before.
  • A 53-year-old male presented with symptoms including mild right hemiplegia, and imaging confirmed the tumor at the cervical spine; pre-surgery angiography helped minimize bleeding during the complete resection of the tumor.
  • Post-surgery, the patient showed improved motor and sensory functions, and pathology confirmed the tumor type; findings aligned with literature indicating combined surgical approaches are best for managing this rare condition while reducing risks associated with
View Article and Find Full Text PDF

Early identification of patients at risk with von Hippel-Lindau (VHL) syndrome-related pheochromocytoma and paraganglioma (PPGL) is crucial to prevent morbidity. We investigated the current surveillance recommendations in VHL-related PPGL in children and adolescents. German Pediatric Oncology and Hematology-Malignant Endocrine Tumor registry (GPOH-MET) and Freiburg-VHL registry (1996-2022).

View Article and Find Full Text PDF

Diagnostic Role of Oral Fluorescein Angiography in Pediatric Ambulatory Clinics.

Ophthalmol Retina

October 2023

Division of Ophthalmology, Seattle Children's Hospital, Seattle, WA, 98105; Department of Ophthalmology and Roger and Karalis Johnson Retina Center, University of Washington, Seattle, WA, 98109; Brotman Baty Institute for Precision Medicine, Seattle, WA 98195. Electronic address:

Article Synopsis
  • Oral fluorescein can be taken safely in pediatric clinics for diagnosis.
  • Ultra-widefield fluorescein angiography is a quick, non-invasive method used for examining children's retinal blood vessel issues.
  • This technique helps in the fast diagnosis and effective management of various retinal vascular diseases in kids.
View Article and Find Full Text PDF
Article Synopsis
  • Von Hippel-Lindau is a rare genetic disorder with an autosomal dominant inheritance pattern, leading to multiple vascular tumors, especially in the brain, eyes, and organs.
  • The disease can manifest at any age, with retinal tumors often being one of the first signs; MRI and fluorescein angiography are key diagnostic tools.
  • A case study highlights a woman in her late 30s with vision loss, revealing various eye and kidney abnormalities, including cystic lesions in her brain and elevated urine protein levels.
View Article and Find Full Text PDF

Pediatric Spinal Vascular Abnormalities: Overview, Diagnosis, and Management.

Neuroimaging Clin N Am

November 2024

Department of Radiology, Neurology & Neurosurgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA; Section of Interventional Neuroradiology, Department of Radiology, Northwestern Memorial Hospital, 676 North Street, Clair street, Suite 1400, Chicago, IL 60611, USA.

Article Synopsis
  • * Spinal cord hemangioblastomas make up a small percentage (1.1% to 2.4%) of central nervous system tumors, typically presenting as single tumors in adults around their 40s, while they are rare in children, especially those without VHL syndrome.
  • * The thoracic spinal cord is the most common location for these tumors, which can lead to serious symptoms like spinal cord compression and bleeding, despite being classified as benign.
View Article and Find Full Text PDF

Background And Objectives: The role of radiosurgery in the treatment of benign intracranial tumors is well established. However, there are limited long-term follow-up studies on outcomes after stereotactic radiosurgery (SRS) for benign intradural spinal tumors. In this article, we report a large single-institution experience in using SRS to treat patients with benign intradural tumors of the spine.

View Article and Find Full Text PDF

Spinal cord hemangioblastomas in von Hippel-Lindau disease.

Neurooncol Adv

October 2024

Department of Neurological Surgery, Ohio State University Wexner Medical Center, Ohio State University, Columbus, Ohio, USA.

Background: von Hippel-Lindau disease (VHL) is an autosomal dominant familial neoplasia syndrome. The most common manifestation of VHL is central nervous system hemangioblastomas. VHL patients will often develop multiple hemangioblastomas along their craniospinal axis over their lifetime.

View Article and Find Full Text PDF

Pediatric patients with von Hippel-Lindau and hemangioblastomas treated successfully with belzutifan.

Pediatr Blood Cancer

January 2025

Division of Pediatric Hematology/Oncology, UCLA, Los Angeles, California, USA.

Article Synopsis
  • * Five pediatric patients with VHL-associated hemangioblastomas were treated with belzutifan, leading to improvements in tumor size and vision for those with retinal lesions, and benefits in neurologic symptoms for patients with intracranial tumors.
  • * The treatment resulted in minor side effects, such as grade 1-2 anemia in four patients, and suggests belzutifan could be a promising therapy for young patients with these tumors.
View Article and Find Full Text PDF
Article Synopsis
  • This report investigates the relationship between genes and the physical traits of retinal hemangioblastoma (RH) in patients with von Hippel-Lindau (VHL) disease.
  • The study looked at 77 patients with confirmed VHL disease and categorized them based on specific genetic mutations affecting RH presence and characteristics.
  • Findings indicate that certain mutations (HIF-1α binding site and truncating mutations) are associated with a higher occurrence and severity of RH compared to other mutations, emphasizing the significance of mutation type in assessing RH risk.
View Article and Find Full Text PDF

Background: To investigate the unique properties of clinical manifestation and radiological imaging for differential diagnosis of optic nerve hemangioblastoma (ONH) from adult optic nerve glioma (ONG) prior to surgical resection.

Methods: ONH and adult ONG patients were recruited from 2012 to 2022.

Results: A total of seven ONH patients (8 eyes) and 23 adult ONG patients (24 eyes) were assessed.

View Article and Find Full Text PDF

Objective: This research aims to examine the expression of carbonic anhydrase IX (CAIX) protein in hemangioblastoma of the central nervous system and its potential application in pathological diagnosis and differential diagnosis.

Materials And Methods: Immunohistochemistry was used to identify the expression of CAIX and the α-inhibin protein. The sensitivity and specificity of CAIX and α-inhibin for identifying hemangioblastoma of the central nervous system were compared.

View Article and Find Full Text PDF

Phenotypic and Genotypic Features of a Chinese Cohort with Retinal Hemangioblastoma.

Genes (Basel)

September 2024

Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, No.1 Dongjiaominxiang, Beijing 100730, China.

Article Synopsis
  • - The study investigated the relationship between genetic factors and the phenotype of retinal hemangioblastomas (RH) in a Chinese group of 51 individuals, using advanced genetic testing methods to identify mutations in the Von Hippel-Lindau (VHL) gene.
  • - Out of the participants, 36 were diagnosed with VHL syndrome, showing a younger median age of onset, while 15 were excluded from this diagnosis; four novel genetic variants were found, alongside established mutation hotspots.
  • - The classification of RH types showed a predominance of extrapapillary lesions in the peripheral retina, and high frequencies of both major genomic deletions and CNS hemangioblastomas in affected families suggest that RH may be an early warning sign for
View Article and Find Full Text PDF

A nonsecreting suprasellar ectopic pituitary adenoma: A case report.

Radiol Case Rep

December 2024

Department of Neuroradiology, Faculty of Medicine and Pharmacy, Specialty Hospital, University Hospital Center Ibn Sina, Abderrahim Bouabid Avenue, 10000, Rabat, Morocco.

Article Synopsis
  • A pituitary adenoma located in the suprasellar region without affecting the Sella turcica is rare, with limited documented cases in medical literature.
  • Accurate diagnosis relies heavily on imaging techniques like MRI, which helps differentiate it from similar conditions including a Rathke cleft cyst, various tumors, and infections.
  • The case of a 48-year-old woman with vision issues demonstrated the presence of an ectopic pituitary adenoma near critical brain structures such as the pituitary stalk and optic chiasm.
View Article and Find Full Text PDF

Total loss of gene function impairs neuroendocrine cancer cell fitness due to excessive HIF2α activity.

Proc Natl Acad Sci U S A

October 2024

Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215.

Loss-of-function germline () tumor suppressor mutations cause VHL disease, which predisposes individuals to kidney cancer, hemangioblastomas, and paragangliomas. The risk that a given VHL disease family will manifest some or all these tumor types is profoundly influenced by the allele it carries. For example, almost all VHL disease families that develop paraganglioma have missense mutations.

View Article and Find Full Text PDF

Hemangioblastoma is a rare benign vascular tumor that occurs mostly in the cerebellum. The aim of the present study was to analyze the clinical characteristics of sporadic cerebellar hemangioblastoma and its surgical strategy. A total of 76 cases of sporadic cerebellar hemangioblastoma (42 males and 34 females; age, 46.

View Article and Find Full Text PDF
Article Synopsis
  • - The LITESPARK-004 study is testing the hypoxia-inducible factor-2α inhibitor, belzutifan, for its effectiveness in treating tumors associated with von Hippel-Lindau disease, specifically focusing on patients with central nervous system (CNS) haemangioblastomas after additional follow-up.
  • - A total of 61 patients, with a majority having CNS haemangioblastomas, were enrolled in this phase 2 study across multiple cancer centers in four countries, and they received oral belzutifan until there were unacceptable side effects or disease progression.
  • - The study assesses the antitumor activity by evaluating patient responses using two different methods based on tumor measurements and is ongoing, with results still being
View Article and Find Full Text PDF